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Abstract
The role of myogenic enhancer transcription factor 2a (MEF2A) in avian muscle during fetal development is un-
known. In this work, we cloned the duck MEF2A cDNA sequence (GenBank accession no. HM460752) and exam-
ined its developmental expression profiles in cardiac muscle, non-vascular smooth muscle and skeletal muscle.
Duck MEF2A cDNA comprised 1479 bp encoding 492 amino acid residues. In silico analysis showed that MEF2A
contained MADS (MCM1, AGAMOUS, DEFICIENS and SRF - serum response factor), MEF2 and mitogen-activated
protein kinase (MAPK) transcription domains with high homology to related proteins in other species. Modified sites
in these domains were conserved among species and several variants were found. Quantitative PCR showed that
MEF2A was expressed in all three muscles at each developmental stage examined, with the expression in smooth
muscle being higher than in the other muscles. These results indicate that the conserved domains of duck MEF2A,
including the MADS and MEF2 domains, are important for MEF2A transcription factor function. The expression of
MEF2A in duck smooth muscle and cardiac muscle suggests that MEF2A plays a role in these two tissues.
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Introduction
Animals possess three major types of muscle,
namely,cardiac,skeletalandsmoothmusclethatareessen-
tial for movement (Byers et al., 1991; Handschin et al.,
2007; Leong et al., 2008; MacDonald, 2008). The develop-
mentalstagesfromembryoformationtobirthareimportant
for muscle development (Rehfeldt, 2005). The skeletal
muscle mass of adult animals is determined early in devel-
opmentand,inmostanimals,thereisnopost-natalincrease
in the number of myofibers. Post-natal muscle hypertrophy
involves only myofiber lengthening and thickening (Chau-
vigne, 2005). Although the heart is one of the earliest or-
gans formed during embryogenesis (Forouhar et al., 2006),
subsequent development is nevertheless important because
heart muscle development is completed during this stage
(Noorlander et al., 2008). The fetal stage is also important
for smooth muscle maturation and the initiation of physio-
logical functions (Olson, 2006). Muscle development in
this stage is regulated by many genes such as muscle regu-
lar factors (MRFs) and myostatin (MSTN) (Owens et al.,
2004; Olson, 2006; Potthoff and Olson, 2007). However,
only the myogenic enhancer transcription factor 2a
(MEF2A) gene has been reported to be expressed in all
three muscle tissues (Edmondson et al., 1994; Wang et al.,
2000).
MEF2Aisamuscle-specificfactorthatbelongstothe
MEF2 gene family. In mammals, four members of the gene
family have been identified, i.e., MEF2A, -B, -C and -D.
MEF2A is involved in a variety of muscle responses, in-
cluding skeletal muscle myofiber differentiation, smooth
muscle maturation, and normal development of cardiac
muscle (Edmondson et al.,, 1994; Wang et al.,, 2000;
Potthoff and Olson, 2007). In addition to muscle, MEF2A
is expressed in neuronal cells and at low levels in a wide
range of cell types during embryogenesis and adulthood. In
skeletal muscle, MEF2A plays a cooperative role with the
MRF gene family in inducing muscle hypertrophy (Mol-
kentin et al., 1995; Black and Olson, 1998), and its poly-
morphisms are associated with growth traits in Chinese
indigenous cattle breeds (Chen et al., 2010) and with mus-
cle growth in chickens (Zhou et al., 2010). MEF2A is also
highly expressed in the heart during zebrafish embryo-
genesis (Wang YX et al., 2005). Mice lacking MEF2A dis-
play an array of cardiovascular defects that cause most to
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Research Articledie suddenly (Naya et al., 2002). MEF2A polymorphisms
have been associated with several cardiac diseases in hu-
man and may account for 1.93% of such diseases (Wang Q
et al., 2005). The MEF2A gene also plays a role in smooth
muscle cell proliferation and contraction and is expressed
in smooth muscle mainly during adulthood (Firulli et al.,
1996).AlmostallofthestudiesofMEF2Ahavefocusedon
in its functions during embryogenesis and in adulthood. In
contrast, there have been no studies of the roles of MEF2A
in muscle tissues during fetal development.
Most studies of MEF2A have used mammals as a
model, although MEF2A and MEF2D have also been stud-
ied in birds (Buchberger and Arnold, 1999; Xue et al.,
2000).BuchbergerandArnold(1999)reportedthatchicken
MEF2A has a role avian in skeletal muscle and cardiac
muscle, although the precise functions of this protein are
still unclear. In this work, we examined the functions of
MEF2A in muscle tissue from the Pekin duck, a famous
meat poultry breed. The coding sequence of duck MEF2A
was cloned and its expression profile in muscle during fetal
development was determined using real-time PCR. These
results provide essential data for elucidating the roles of
MEF2A in muscle tissue and may also provide new clues
for improving muscle production in duck breeding.
Materials and Methods
Tissues collection and total RNA extraction
All procedures were approved by the Guidelines on
Humane Treatment of Laboratory Animals (2006). Twenty
fivePekinduck(Anasplatyrhynchos)embryos(embryonic
age: 10, 14, 18, 22 or 27 days old, designated E10d, E14d,
E18d, E22d and E27d, respectively) and five neonates (one
week post-natal, designated as p7d) were used. All of the
embryosandbirdswerefromtheSichuanAgriculturalUni-
versity Waterfowl Breeding Experimental Farm. The
hatching embryos and birds were maintained under the
same conditions. For each embryo and newborn bird, ap-
proximately 2 g of tissue was collected from the heart,
small intestine and leg muscle. The samples were immedi-
atelyfrozeninliquidnitrogenandstoredat-86°CforRNA
extraction. Total RNA was extracted using Trizol (Invi-
trogen, USA) according to the manufacturer’s instructions
and then measured spectrophotometrically. First-strand
cDNA was obtained from 10 g of total RNA using a
cDNAsynthesiskit(Takara,Japan)accordingtothemanu-
facturer’s instruction.
Cloning and sequencing of the duck MEF2A CDS
All of the primers were designed using Primer Pre-
mier 5 software and were synthesized by the Shanghai
Yingjun Biology Company. The primers used to amplify
the duck MEF2A gene coding sequence (CDS) are shown
in Table 1. Two microliters of the cDNA mix was used as a
template in a 20 L PCR reaction volume. The reaction
conditions included denaturation for 5 min at 94 °C fol-
lowed by 30 cycles of amplification at 94 °C for 30 s, 56 °C
for30s,and72°Cfor1min,withafinalextensionat72°C
for 10 min. The PCR products were separated by electro-
phoresis on a 1% agarose gel and purified using a gel ex-
traction kit (Watson Biomedical Inc., Shanghai, China).
The purified PCR products were ligated into the pGEM-
19T vector (Invitrogen). Positive clones were selected and
sequenced by the Shanghai Yingjun Biology Company.
ThecDNAsegmentsobtainedfromsequencingwereedited
and assembled with Editseq and Seqman in DNAstar soft-
ware (DNASTAR Inc., Madison, WI, USA)
Real-time PCR
The levels of MEF2A mRNA expression in duck
muscles at different developmental stages were measured
by real-time PCR using a 96-well iCycler IQ5 (BioRad,
USA) and Takara ExTaq RT-PCR kits with SYBR green
(Takara, Dalian, China). One sample was collected from
each muscle type, each bird and each stage, and the real-
time PCR were repeated three times together for each sam-
ple. Duck -actin (EF667345) and duck glyceraldehyde-
3-phosphate dehydrogenase (GAPDH, AY436595), the se-
quences of which were obtained from GenBank, were used
as internal controls. The real-time PCR primers were de-
signed using Primer 5 software (Primer Biosoft Interna-
tional, USA) and are shown in Table 2. The primers were
synthesized by the Shanghai Yingjun Biology Company.
Amplicons corresponding to each target gene were exam-
ined by agarose gel electrophoresis to confirm the presence
of a single band of the expected size. The procedure for
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Table 1 - PCR primers used for cloning of MEF2A coding sequence.
MEF2A Primer sequence Product length (bp) Annealing temperature (°C) Reference gene information
Primer 1 F: 5’ATGGGGAGAAAGAAAATACA3’
R: 5’AAGTAATCGTCAGCATCAGG3’
314 55 Chicken (NM_204184)
Primer 2 F: 5’ GAAGAGGAAGTTTGGATT3’
R: 5’ ATGTTGATGTTTTGGTTG3’
1143 51 Human (NM_002479)
Primer 3 F: 5’ CAGGGACTGGTGTATTCGG3’
R: 5’ TGTCACCCACGTGTCCATC3’
528 52.5 Mouse (NM_001033713)
F, R – forward and reverse primers, respectively.real-time PCR was as follows: 10 s of pre-denaturation at
95 °C, followed by 45 cycles of 95 °C for 5 s and 62 °C for
30 s. PCR products were diluted 16-fold and used to gener-
ate the calibration curve and determine the PCR amplifica-
tion efficiency (Eff) for each gene (MEF2A, -actin and
GAPDH, provided in Table 2).
The relative mRNA expression for target genes was
determined with the following formula after obtaining the
Ctvalueofthegeneofinterest(MEF2A)andtheCtvalueof
the internal control genes:
Rel. quantity
GOI
GOI
Norm
Norm
sample
control
sample
con

trol
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(Ct -Ct )
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(Ct
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c 
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The relative quantity (Rel. quantity) is the multiple of
the differential expression of the gene of interest (GOI) be-
tweenthetestsamplesandcontrolsamples.Thenormalizer
(Norm) is the reference gene and the PCR amplification ef-
ficiency is represented by Eff.
Statistical analysis
BLASTn(NCBI)wasusedtoidentifythegene.Anal-
ysis of the nucleotide and amino acid sequences, prediction
of secondary structure and multiple sequence alignment
were done with Editseq, Protean, and MegAlign in
DNAstar, respectively. Conserved domains in the protein
were analyzed using the CD-search tool available from
NCBI. Phylogenetic trees were constructed with MEGA
4.0 software by the neighbor-joining method and bootstrap
sampling 1,000 times.
The real-time PCR data were subjected to analysis of
variance (ANOVA) and the means were compared for sig-
nificance by Tukey’s test. The ANOVA and t-tests were
done with SAS (SAS Institute, Cary, NC, USA) software.
A p-value of p < 0.05 was considered statistically signifi-
cant.
Results
Comparison of duck MEF2A with other species
After sequencing and assembling of the fragments,
the total coding sequence of duck MEF2A was obtained
and submitted to GenBank (GenBank accession no.
HM460752). This consisted of 1479 nucleotides encoding
492 amino acids and showed high similarity with the
chicken sequence (92.8% similarity at the nucleotide level
and 93.5% at the amino acid level; Table 3).
Phylogenetic tree construction
The phylogenetic tree constructed based on verte-
brate MEF2A amino acid sequences showed that the se-
quences formed three main groups: mammalian MEF2A,
fishMEF2AandavianMEF2A(Figure1).ACD-searchon
NCBI revealed that duck MEF2A had three conserved do-
mains in the peptide strands, i.e., the MADS (aa 3-57),
MEF2 (aa 58-86) and MAPK (mitogen-activated protein
kinase)bindingdomains(aa264-285),butlackedabetado-
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Table 2 - Primers for real-time PCR analysis.
Gene Primer sequence Product length (bp) Tm (°C) Amplification efficiency (%)
MEF2A F: 5’ GGGTATGATGCCACCATTGAA 3’
R: 5’ GGTCTGCGCTAGTCAAGGAGTAA 3’
170 59.5 98
-actin F: 5’ GCTATGTCGCCCTGGATTTC 3’
R: 5’ CACAGGACTCCATACCCAAGAA 3’
168 59.6 97
GAPDH F: 5’ AAGGCTGAGAATGGGAAAC 3’
R: 5’ TTCAGGGACTTGTCATACTTC 3’
254 53.9 95
F, R – forward and reverse primers, respectively.
Table 3 - Homology of MEF2A in several vertebrate species.
Species [Latin name] Nucleotide (%) Amino acid (%)
Chicken [Gallus gallus] 92.8 93.5
Human [Homo sapiens] 80.4 84.2
Mouse [Mus musculus] 82.2 88.2
Ox [Bos taurus] 80.4 82.8
Pig [Sus scrofa] 82.7 86.0
Zebrafish [Danio rerio] 74.1 73.8
African frog [Xenopus laevis] 71.3 75.7
Figure 1 - Phylogram of MEF2A amino acid sequences constructed using
the neighbor-joining method. The predicted amino acid sequence of duck
MEF2AandthelongformMEF2Aofotherspecieswereusedinthisanal-
ysis. The phylogenetic tree was constructed using MEGA software with
the neighbor-joining method and bootstrap resampling (1,000 times). The
numbers indicate the bootstrap value (%). Reference species: Gallus
gallus (chicken) NP_990195, Homo sapiens (human) NP_005578, Bos
taurus (ox) NP_001077107, Sus scrofa (pig) EF576923, Mus musculus
(mouse) ABQ53160 and Danio rerio (zebrafish) NP_571376.main that is present in other organisms, except for
zebrafish. There were no amino acid variants in the three
conserveddomainsoftheduckandchickenproteins.These
threeregionswerealsohighlyconservedbetweenbirdsand
mammals. Only two variant residues were observed in the
porcine MEF2A, MADS and MEF2 domains compared
with other mammals, in addition to a single residue change
from ‘N’ in avian sequences to ‘S’ in mammalian and fish
(zebrafish)sequences;thelatteralsoshowedtwoadditional
amino acid changes compared to the avian sequences.
Several modified residues were identified in MEF2A
in addition to the conserved domains of MEF2A. Most of
these were conserved among species, including acetylly-
sinesitesatpositions117,248,253and394,phosphoserine
sites at positions 98, 221, 233, 346, 399 and 439, and
phosphothreonine sites at positions 302 and 310. Several
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Figure 2 - Alignment of the predicted amino acid sequence of duck MEF2A with the corresponding sequences of other vertebrates. The numbers on the
right indicate the residue positions. Dashes (- - -) indicate the same (unchanged) amino acids and dots () indicate the absence of amino acids (insertion of
spacestoimprovealignment).ThesequenceswerecomparedusingDNAMANsoftware.TheGenBankaccessionnumbersofeachspeciesareasfollows:
Gallus gallus (chicken) NM_204864, Homo sapiens (human) NM_005587, Sus scrofa (pig) EF576923, Mus musculus (mouse) NM_001033713 and
Danio rerio (zebrafish) NP_571376.1. K - acetyllysine site, S - phosphoserine site and T - phosphothreonine site.modified sites differed between birds and mammals, such
as the phosphoserine sites at positions 148, 153, 175, 176,
208 and 267. The modified sites could be grouped into four
regions, identified as regions 1, 2 and 3 (D1, D2, and D3,
respectively)andaregionofvariants1(V1)(Figure3).The
D1-D3 regions had the same characteristics as avian (duck
and chick) MEF2A, which differed from those of mam-
mals. The V1 region varied in all of the species examined.
The secondary structures of the D1-D3 and V1 regions
were predicted using the protean program in DANstar, and
the results showed that the secondary structure distribu-
tions in the D1-D3 regions differed between birds and
mammals (Figure 3).
Expression profiles of duck MEF2A in muscles
during fetal development
Figures 4-6 show the expression profiles of duck
MEF2A. MEF2A was expressed in skeletal, smooth and
cardiac muscle at each developmental stage examined. The
expression level was higher in smooth muscle than in the
other two muscles. In cardiac muscle, MEF2A showed a
significant change (increase) only at embryo stage 27d,
when the eggs were close to hatching. In skeletal muscle,
MEF2A expression increased from embryo stage 10d to
18d, after which it decreased from embryo stage 22d on-
wards; at postnatal 7d the expression was lower than in any
of the preceding periods. In smooth muscle, there was a
progressive increase in MEF2A expression up to 22d, fol-
lowed by a slight decline in later periods.
Discussion
Identification and functional prediction of duck
MEF2A
MEF2A is one of the MEF2 gene family members
and in birds has so far been cloned only from chicken
(Buchberger and Arnold, 1999). Duck MEF2A is the sec-
ond member of avian origin to be cloned. It shared > 90%
identity with the chicken protein at the nucleotide and
amino acid levels. An in silico analysis showed that duck
MEF2A contained a MADS domain in its N-terminal, fol-
lowedbyaMEF2domain.Thisstructuralorganizationwas
similar to the corresponding chicken and mammalian pro-
teins (Buchberger and Arnold, 1999; Huang et al., 2000;
Wuetal.,2010).TheMADSdomainisreportedlyinvolved
in specific DNA binding and dimerization while the MEF2
domain increases DNA binding and mediates the interac-
tion of MEF2 proteins with other cofactors such as GATA,
ERK5 and HDAC. The duck MEF2A gene also had an
evolutionarily conserved regulatory region for interaction
with MAPKs. The three conserved domains (MADS,
MEF2 and MAPK) show few variants among different or-
ganisms, which suggests that duck MEF2A plays a similar
role to the corresponding protein in other species.
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Figure 3 - Secondary structure prediction of the D1, D2, D3 and V1 regions in Figure 1 and prediction of processing using the protean program in
DNAstarsoftware,basedontheChou-Fasmanmathematicmodel.Thenumbersinthefigurerepresentaminoacidpositions.A-helix,B-sheetandT
- random turn.Vertebrate MEF2A amino acid sequences contain
many modified sites that could be involved in MEF2A
function (Zhao et al., 1999). Most of the modified sites in
the conserved regions are the same among different organ-
isms, indicating a role in regulating the stability and func-
tion of MEF2A (Cox et al., 2003). The MAPK domain in
the C-terminal region of MEF2A may play a role in signal
transduction (Barsyte-Lovejoy et al., 2004). Figure 2
showsanaminoacidsubstitutionintheMAPKdomain,viz.
an Asn residue in birds that is Ser (a phosphorylation site)
in mammals. This substitution suggests that the function of
the MAPK domain in birds may be different from that in
mammals. There are also modified sites outside of the con-
served domains, including Ser408 (Ser399 in duck),
Ser355(Ser346induck),Lys403(Lys394induck),Thr312
(Thr303 in duck) and Thr319 (Thr310 in duck). Phospho-
rylation and dephosphorylation of Ser408 in human
MEF2A prevents acetylation of Lys403 and acetylation of
Lys403, respectively, which inhibits dendrite claw differ-
entiationinmammals(Coxetal.,2003;Flavelletal.,2006;
Shalizi et al., 2006). Phosphorylation of Thr312 and
Thr319 is involved in p38 MAPK signaling and the activa-
tionoftranscription(Zhaoetal.,1999;HanandMolkentin,
2000; Lee et al., 2000). Phosphorylation of Ser408 by
CDK5,whichisinducedbyneurotoxicity,inhibitsMEF2A
transcriptional activation, leading to apoptosis of cortical
neurons (Gong et al., 2003). Phosphorylation of Thr312,
Thr319 and Ser355 can be induced by EGF sumoylation at
Lys403, which is enhanced by PIAS1 and represses trans-
criptional activity (Kato et al., 2000). Acetylation of Lys4
increases DNA binding, transactivation and hyperacetyl-
ationbyp300,leadingtoenhancedcardiacmyocytegrowth
and heart failure (Angelelli et al., 2008). These modified
sites are conserved among birds and mammals, indicating
similarly conserved functions in different organisms.
Developmental expression of MEF2A in duck
muscle during the muscle development stage
Previous studies of MEF2A have focused on its func-
tions during embryogenesis and in adulthood. Our results
show that duck MEF2A was expressed in cardiac, smooth
and skeletal muscle during fetal development. In skeletal
muscle, MEF2A expression increased to reach a peak at
embryonic day 18, followed by a subsequent decrease.
Buchberger and Arnold (1999) reported that in chickens
MEF2A expression was not detected in newly formed so-
mites until the muscle-specific transcription factors MyoD
and myogenin were present, indicating that activation of
theMEF2Ageneinskeletalmusclewasdependentonthese
basichelix-loop-helixtranscriptionfactors.Wehaveexam-
ined the developmental expression of duck MyoG and
MRF4 in skeletal muscle during the fetal stage and found
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Figure 5 - Expression profile of MEF2A in duck skeletal muscle during
development. Different letters indicate a significant difference (p < 0.05)
in gene expression during development whereas the same letters indicate
no difference. p7d - first post-natal week. The columns represent the
means  SEM of 5 muscles in each stage.
Figure 6 - Expression profile of MEF2A in duck smooth muscle during
development. Different letters indicate a significant difference (p < 0.05)
in gene expression during development whereas the same letters indicate
no difference. p7d - first post-natal week. The columns represent the
means  SEM of 5 muscles in each stage.
Figure 4 - Expression profile of MEF2A in duck cardiac muscle during
development. Different letters indicate a significant difference (p < 0.05)
in gene expression during development whereas the same letters indicate
no difference. p7d - first post-natal week. The columns represent the
means  SEM of 5 muscles in each stage.that MyoG and MRF4 are highly expressed in the leg mus-
clesatembryonicdays14dand18d,respectively(Liuetal.,
2010), which is before the peak expression of MEF2A. Our
results are consistent with those of Buchberger and Arnold
(1999) and suggest that activation of the MEF2A gene in
skeletal muscle is dependent on these basic helix-loop-
helix transcription factors.
Myocardialmuscledevelopsmainlyduringearlyem-
bryogenesis and MEF2A is highly expressed in zebrafish
heart during embryogenesis (Mathavan et al., 2005; Wang
Q et al., 2005). In chickens, MEF2A expression is first ob-
served in the precardiac mesoderm of HH stage 8 embryos,
and expression in heart and skeletal muscle continues into
adulthood, when it is also observed in the intestinal mesen-
chyme and brain. During later embryonic development,
MEF2A expression continues in the heart tube and later in
the atrium and ventricle (Buchberger and Arnold, 1999;
Czubryt and Olson, 2004). Our results support the above
findings since MEF2A was found to be expressed at a
steady level up to 22d, with a peak at 27d. This change in
expression as the egg approaches hatching may enable the
duckling to adapt to a new environment when the heart will
mature further.
MEF2A is thought to be important for the activation
and expression of contractile proteins and other muscle-
specificfactorsinskeletalandcardiacmuscle(Czubrytand
Olson, 2004). Firulli et al. (1996) showed that MEF2A is
highlyexpressedinsmoothcellsproducingcontractilepro-
teins. Duck MEF2A was highly expressed in smooth mus-
cle at almost all of the fetal stages, with greater expression
than in skeletal and cardiac muscle. The elevated expres-
sion of duck MEF2A in smooth muscle during these stages
suggests that this protein has an important role in smooth
muscle development.
Relationship between MEF2A expression and
protein structure
MEF2 binds directly to the promoters or enhancers of
the majority of muscle-specific genes (Naya and Olson,
1999), and virtually all muscle genes, including MRFs,
have MEF2 binding sites in their regulatory regions (Mes-
sina et al., 2010). The MADS box and adjacent MEF2 do-
mainofMEF2proteinsplayacooperativeroleinbindingto
theregulatoryregionsofmusclegenes(PotthoffandOlson,
2007; Ramachandran et al., 2008) to activate skeletal mus-
cle differentiation. However, unlike MRFs, MEF2 factors
cannot activate myogenesis alone but, instead, combine
with MRFs through protein-protein interactions in the
MADS box and bHLH domain to vastly improve the effi-
ciencyofthemyogenicprogram(Kaushaletal.,1994).The
MEF2A domains in poultry are homologous to those of
mammals. Duck MEF2A lacks a beta domain region that is
present in chickens and other species; this domain may be
alternatively spliced in humans (Yu et al., 1992). The RNA
transcripts of all MEF2 members undergo alternative splic-
ing, with some of these being limited to specific cell types
(Yu, 1996). The significance of these alternative splicing
events is not yet understood.
The analysis of human tissues has shown that
MEF2A is expressed only in skeletal and cardiac muscle
and in the brain, while two isoforms of MEF2A that lack a
beta domain region are expressed in all tissues examined
(Pollock and Treisman, 1991). The duck MEF2A sequence
cloned here was expressed in all three types of muscle, a
finding similar to that for the two MEF2A isoforms in hu-
mans. We suggest that the duck MEF2A sequence cloned
here may be only one of several alternatively spliced
isoforms, and that the tissue expression of duck MEF2A
maydifferfromthatofotherorganisms.Thesepossibilities
warrant further study.
The modified sites in MEF2A are important for regu-
lating gene expression and function. The phosphorylation
status of MEF2A is a critical determinant of its tissue-
specific functions and can be directly regulated by tis-
sue-specific pathways acting on selected amino acid resi-
dues (Wang et al., 2004). Pathways such as p38 MAPK
signaling have an important role in regulating cardiac and
smooth muscle function (Dentel et al., 2005). As shown
here, there are several important differences in the amino
acid sequences of avian and mammalian MEF2A. Al-
though the influence of amino acid alterations on MEF2A
function, especially in the D1-D3 and V1 regions, was not
examined here, these novel modified sites may be involved
in the differential regulation of gene expression and func-
tion in avian and mammalian muscle.
In conclusion, duck MEF2A contains MADS, MEF2
and MAPK domains that share high similarity with related
domainsinotherspecies.Theseconserveddomainsareim-
portant for maintaining protein functions. The expression
of MEF2A in duck cardiac, smooth and skeletal muscle
suggests an important role for this protein in muscle devel-
opment.
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